Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

5 clinical trials · Sponsor

Record	Firm	Date
Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer. (NCT06716775)	Jiangsu Healthy Life Innovation Medical Technology Co., Ltd	2024-12-20
A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers (NCT06611345)	Jiangsu Healthy Life Innovation Medical Technology Co., Ltd	2024-10-21
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. (NCT06353360)	Jiangsu Healthy Life Innovation Medical Technology Co., Ltd	2024-04-30
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer (NCT05653453)	Jiangsu Healthy Life Innovation Medical Technology Co., Ltd	2022-12-20
Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment (NCT05661240)	Jiangsu Healthy Life Innovation Medical Technology Co., Ltd	2022-12-20

Every clearance here is in the API, with alerts when new ones post.